Akums
Haridwar, India· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
India's leading CDMO delivering high‑volume, regulated pharmaceutical manufacturing across multiple therapeutic segments.
OncologyCardiovascularDiabetesNeurologyGynecologyNephrologyAnti-infectivesRespiratoryAnalgesicsNutraceutical
Technology Platform
A vertically integrated, GMP‑compliant manufacturing platform combined with a robust R&D hub that develops advanced formulation technologies (modified‑release, pediatric soft‑chews, sterile injectables, cosmeceuticals) and API production meeting WHO‑GMP, USFDA, EU‑GMP, and TGA standards.
Opportunities
Expansion into biologics manufacturing, increased export demand for complex dosage forms, and leveraging digital manufacturing to enhance efficiency and capacity utilization.
Risk Factors
Regulatory changes, high competition from other Indian CDMOs, and potential under‑utilization of large manufacturing capacity.
Competitive Landscape
Competes with Indian CDMOs such as Divi’s Laboratories, Piramal Enterprises, and Suven Pharma, differentiating through its extensive API capabilities, broad dosage‑form expertise, and strong regulatory compliance record.